Post-Transplant Malignancy: Treatments
Tuesday, May 21, 2024 - 14:00 to 15:00
After participating in this webinar, the attendee will be able to:
- Update knowledge on the epidemiology of post-transplant cancer.
- Illustrate examples of comprehensive, integrated cancer and transplant clinic.
- Review the updated data on cancer therapies for post-transplant cancers (e.g. immunotherapy and cellular therapies).
Speakers:
- Naoka Murakami, MD, PhD, FAST • Assistant Professor, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA
- Chris Blosser, MD, FAST • Professor, University of Washington, Fred Hutch Cancer Center and Seattle Children’s Hospital, Seattle, WA
Moderator:
- Kenar Jhaveri, MD • Professor in Medicine, Northwell Health, New Hyde Park, NY
The AST Education Committee would like to thank the Thoracic and Critical Care Community of Practice (TCC COP), Kidney Pancreas Community of Practice (KPCOP), Liver and Intestinal Community of Practice (LICOP) and others for suggesting the core topic of "Post-Transplant Malignancy" as part of the 2023-2024 T3 webinar series. Learn more about AST's COPs at www.myast.org/cops .
Education Category:
Series category:
T3: Timely Topics in Transplantion